you mean pharmaceuticals? here you go..

generic &specialty : “http://www.reuters.com/finance/industries/overview?industryCode=56213”

diversified – maybe diworsified : “http://www.reuters.com/finance/industries/overview?industryCode=56211”

Mitsubishi Tanabe Pharma Corporation는 뭐 하는 회사인가요?

매출이 300조가 넘는데……

그리고 궁금한 것은 generic & specialty와 diversified는 어떻게 나뉘는 건가요? Generic이 뭔지는 알지만……

제약 쪽에 종사하시는 분께서 쉽게 설명해주시면 좋을 듯 한데요.

well, they didnt convert it into dollars! it doesnt seem to manually sort things out.

i found a recent r&d ranking table at below link. thid may be somewhat you look for- got it from the website i usually make a visit. gsk is one of my favorite stock and they have done very well these days.
“http://www.p-d-r.com/ranking/Top50_May_08.pdf”

무슨 소린지 모르겠습니다.

마지막에 올려주신 자료는 재미 있는 자료네요.

뭐 하는 회사인지 물어본 것은……

제약회사겠지만, 도대체 뭐 하는 회사이기에 이렇게 매출이 큰가 하는 점입니다.

에 의하면 R&D activity도 약한 것 같은데 말입니다.

물론 R&D와 매출이 절대적으로 상관이 있는 것은 아니지만……

i have no idea what the company is specifically doomed to make.. no interest = no information. you can dig into the company. look below.. its in millions of yen.. adr stock is usually notated in the local currency that makes us confused occasionally

“http://www.reuters.com/finance/stocks/incomeStatement?stmtType=INC&perType=ANN&symbol=4508.T”

you can also find their market cap and numbers of employees at below link.
“http://www.reuters.com/finance/industries/rankings?industryCode=56213”

also, i believe r&d in this sector is particularly important to forecast its potential growth. gsk is very promising and its operating income has been dramatically improved for last yrs.